$GTHP..FDA response on LuViva PMA application expected by end of May. Virtually no money! http://t.co/ikyFYZRSTY
Highlights: -FDA response on amended LuViva PMA application expected by end of May -Primary sales focus is international screening markets with large unmet need -Several key markets expected to ramp up screening efforts in 2015 -International market opportunity exceeds $2 billion